(Q39210624)

English

Optimizing glioblastoma temozolomide chemotherapy employing lentiviral-based anti-MGMT shRNA technology

scientific article published on 15 January 2013

In more languages
default for all languages
No label defined

No description defined

Statements

Optimizing glioblastoma temozolomide chemotherapy employing lentiviral-based anti-MGMT shRNA technology (English)
0 references
0 references
Parisa Monfared
Sonja Schelhaas
Michael T Kuhlmann
Cornel Fraefel
Andreas H Jacobs

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit